Home

Biotechnology Value Fund reported a 8.5% stake in Kymera Therapeutics KYMR · 6,867,809 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
8.5%
Last report
No earlier report
Shares held
6,867,809 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/12/11
Filed
25/12/15

8.5% stake

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/11~01/10

Biotechnology Value Fund's other 5% stake reports